Health

Otsuka’s Kidney Drug Trial Results Mixed

Updated 2026-06-04 20:05 UTC 1 source Negative

Otsuka's kidney drug Voyxact showed some benefit in slowing the loss of function, but the results were less than expected. The late-stage trial has raised questions about its efficacy.

Coverage timeline — 1 article

STAT News

STAT+: Otsuka kidney drug slowed loss of function, but less than expected, in late-stage trial

Otsuka’s Voyxact slowed the loss of kidney function after one year in patients with a chronic autoimmune kidney disease, but the benefit was less than expected.

2026-06-04 19:59 UTC